Department of Neurology, 980 Hospital of PLA Joint Logistics Support Forces, 398 ZhongShan Xi Road, QiaoXi District, ShiJiaZhuang, Hebei Province, China.
Department of Neurology, Army Medical University Daping Hospital, 10 Changjiang Branch Road, Yuzhong District, Chongqing, 400042, PR China.
Biochem Biophys Res Commun. 2021 Mar 19;545:157-163. doi: 10.1016/j.bbrc.2021.01.072. Epub 2021 Feb 4.
The proliferation and migration of vascular smooth muscle cells (VSMCs) is one of main reasons of vascular remodeling and is the pathogenesis of atherosclerosis and other vascular diseases. Transient receptor potential vanilloid 1 (TRPV1) is the specific receptor of capsaicin. TRPV1 has been previously reported to inhibit proliferation, migration and phenotypic switching, but the regulatory mechanisms and relevant signalling pathways are not clear. The aim of this study was to investigate the effects of capsaicin-activated TRPV1 on VSMC phenotypic switching. In this study, oxidized low density lipoprotein (ox-LDL) was used to induce the proliferation and migration of VSMCs. Our data showed that the VSMC proliferation induced by ox-LDL was dependent on the concentration of ox-LDL. Nevertheless, the data showed that capsaicin activated TRPV1 significantly decreased ox-LDL-induced superoxide anion generation. Phenotypic switching of VSMCs was inhibited by the activation of TRPV1. Furthermore, capsaicin decreased ox-LDL-induced superoxide anion generation by activating peroxisome proliferator activated receptor α (PPARα). TRPV1 inhibited VSMC phenotypic switching via upregulated expression of PPARα. It may be considered a useful target for the treatment of vascular remodeling.
血管平滑肌细胞(VSMCs)的增殖和迁移是血管重构的主要原因之一,也是动脉粥样硬化和其他血管疾病的发病机制。瞬时受体电位香草醛 1 型(TRPV1)是辣椒素的特异性受体。先前有报道称 TRPV1 可抑制增殖、迁移和表型转化,但调节机制和相关信号通路尚不清楚。本研究旨在探讨辣椒素激活 TRPV1 对 VSMC 表型转化的影响。在这项研究中,使用氧化低密度脂蛋白(ox-LDL)诱导 VSMC 的增殖和迁移。我们的数据表明,ox-LDL 诱导的 VSMC 增殖依赖于 ox-LDL 的浓度。然而,数据表明,辣椒素激活 TRPV1 可显著减少 ox-LDL 诱导的超氧阴离子生成。TRPV1 的激活抑制了 VSMC 的表型转化。此外,辣椒素通过激活过氧化物酶体增殖物激活受体α(PPARα)减少 ox-LDL 诱导的超氧阴离子生成。TRPV1 通过上调 PPARα 的表达抑制 VSMC 表型转化。它可能被认为是治疗血管重构的一个有用靶点。